Rising Chronic Diseases To Augment Enteral Nutrition Market Growth

Enteral Nutrition Market
Enteral Nutrition Market

Enteral Nutrition Market by Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient and Others), Form (Powder and Liquid), Age Group (Adults, and Pediatric), and Distribution Channel (Hospital Sales, Retail, and Online) by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Enteral Nutrition Market is estimated to be valued at US$ 7.2 billion in 2023 and is expected to exhibit a CAGR of 5.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Enteral Nutrition, also known as tube feeding or artificial food, is the usage of a special formula offered from a clinical instrument that goes into the stomach or small intestines. It permits people who can’t intake commonly to manage their weight and strength. The physician may suggest tube feeding if one cannot eat or cannot do it properly, for instance because of the head and neck tumor or its treatment, a brain and spinal cord wound such as stroke or ALS, or gastrointestinal tract issues. The physician would select a kind of tube, a particular feeding pump, and an enteral nutrition formula depending on the health, the size and location of the tube, and the digestive capacities and necessities.

Competitive Landscape:

Key players involved in the growth of global Enteral Nutrition Market are ABBOTT LABORATORIES, HORMEL FOODS CORPORATION, DANONE S.A., GLOBAL HEALTH PRODUCTS, INC., MEIJI HOLDINGS CO., LTD., FRESENIUS KABI AG, RECKITT BENCKISER GROUP PLC., NESTLE S.A, B. BRAUN MELSUNGEN AG, VICTUS, INC.

Market Key Drivers:

Increasing prevalence of chronic diseases such as cancer and neurological diseases is expected to boost the growth of global Enteral Nutrition for Market. For instance, as per GLOBOCAN, cancer is the second largest diseases across the globe, approximately 19.3 million people suffer from cancer cases across the globe.

Rising gastrointestinal diseases, diabetes and others are projected to propel the growth of global Enteral Nutrition Market. For instance, as per facts and figures around 4 out of every 10 adults across the globe suffer from gastrointestinal diseases.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global Enteral Nutrition for Market due to the surge in pandemic. The rising cases has led to the closure of clinics, shift of doctors towards curing Covid-19 patients. Lack of beds, healthcare physician and appointments in hospital visits has impeded the market growth.

Key Takeaways:

The global Enteral Nutrition Market is anticipated to exhibit a CAGR of 5.5 % during the forecast period owing to the rising product launches and approvals. For instance, in May 2022, Abbott launched EleCare specialty amino acid-based formulas in kids and children who have serious food allergies or gastrointestinal diseases.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global Enteral Nutrition for Market due to rise in F&B sector, increasing chronic diseases such as cancer, gastrointestinal diseases, diabetes, neurological diseases, rising product launches and approvals. For instance, as per the American Cancer Society, in 2022, around 1.9 million people in U.S suffer from cancer.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more